GZR18 injection effects on stomach emptying and drug interactions
Part of Hormones & metabolism clinical trials.
This trial tests how a new injectable drug, GZR18, affects how fast your stomach empties and how it interacts with other medicines. It is for obese Chinese adults who want to join a research study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are Chinese, aged 18 to 50.
- Your body mass index (BMI) is between 26 and 35.
- You are generally healthy, aside from being overweight or obese.
- You agree to use birth control from now until 8 weeks after the last dose.
- You cannot have certain medical conditions like heart, liver, or digestive diseases, or a history of pancreatitis or gallbladder problems.
- You have not used certain weight-loss drugs or other medications that affect stomach movement recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
This trial tests how a new drug called GZR18 (given as an injection) affects the body in people with different levels of kidney function. It aims to find the right dose and check for side effects, which could help guide treatment for people with kidney issues.
This study tests a new drug called GZR18 to see how it works in people with different levels of liver function. It aims to help find the right dose and check safety.
This trial tests a new injection (GZR102) compared to two other injections (GZR4 and GZR18) in overweight adults. The goal is to see how well the body processes each drug and their effects. It may help researchers find a better treatment for weight management.
This study is for people who finished a previous weight loss trial and want to continue treatment with an injectable medication GZR18. It tests how well the medicine works over a longer period.
This trial tests how a single injection of a new drug called GZR4 is absorbed when given at different injection sites (like the belly or thigh) in healthy men. It helps researchers understand how the drug works in the body before testing it in people with diabetes.
Hear when a new Obesity or Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.